BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21323803)

  • 41. Stability of an autologous platelet clot in the pericardial sac: An experimental and clinical study.
    Rademakers LM; Gründeman PF; Bolderman RW; van der Veen FH; Maessen JG
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1190-4. PubMed ID: 19379990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful ovariectomy in a dog with Glanzmann thrombasthenia.
    Brdecka DJ; Adin CA; Boudreaux MK; Crawford EC; Randall SR
    J Am Vet Med Assoc; 2004 Jun; 224(11):1796-8, 1788. PubMed ID: 15198264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mathematical Analysis of Bleeding Time Data in Patients with Platelet Disorders and von Willebrand's Disease.
    Slack SM; Weiss HJ; Lages B; Turitto VT
    Platelets; 1995; 6(3):169-75. PubMed ID: 21043621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perioperative Hemostatic Management of a Pediatric Patient with Glanzmann Thrombasthenia Undergoing Osteoplastic Craniotomy and Hematoma Removal: A Case Report.
    Lee SM; Kim KN; Kim SY
    Acta Haematol; 2019; 142(4):244-248. PubMed ID: 31085914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A lethal case of massive hemorrhage after percutaneous liver biopsy in a patient with thrombasthenia.
    Kato H; Kanno S; Ohtaki J; Fukuta M; Nakamura Y; Aoki Y
    Leg Med (Tokyo); 2023 Nov; 65():102315. PubMed ID: 37598645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glanzmann thrombasthenia in pregnancy: the value of a probing bleeding history.
    Sharma P; Gogia S; Zafar MS; Saraf A; Bhargava M
    Clin Appl Thromb Hemost; 2012; 18(1):110-2. PubMed ID: 22324052
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral surgery in people with inherited bleeding disorder: A retrospective study.
    Fribourg E; Castet S; Fénelon M; Huguenin Y; Fricain JC; Chuy V; Catros S
    Haemophilia; 2024 Jun; ():. PubMed ID: 38825767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of pregnancy in type 2B von Willebrand disease: case report and literature review.
    Biguzzi E; Siboni SM; Ossola MW; Zaina B; Migliorini AC; Peyvandi F
    Haemophilia; 2015 Jan; 21(1):e98-103. PubMed ID: 25431025
    [No Abstract]   [Full Text] [Related]  

  • 49. High annualized bleeding rates in pediatric patients with inherited platelet function disorders.
    Saini S; Zhang S; Yates S; Garcia J; Sharma R; Formella J; Sarode R; Zia A
    Haematologica; 2024 Mar; ():. PubMed ID: 38546671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the Preference of Local Bleeding to Vanæsection.
    Chirurgicus
    Lond Med Phys J; 1816 Nov; 36(213):364-365. PubMed ID: 30493737
    [No Abstract]   [Full Text] [Related]  

  • 51. Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias.
    Bury L; Falcinelli E; Gresele P
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current and Emerging Options for the Management of Inherited von Willebrand Disease.
    Heijdra JM; Cnossen MH; Leebeek FWG
    Drugs; 2017 Sep; 77(14):1531-1547. PubMed ID: 28791655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autologous blood preparations rich in platelets, fibrin and growth factors.
    Fioravanti C; Frustaci I; Armellin E; Condò R; Arcuri C; Cerroni L
    Oral Implantol (Rome); 2015; 8(4):96-113. PubMed ID: 28042422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inherited, congenital and acquired disorders by hemostasis (vascular, platelet & plasmatic phases) with repercussions in the therapeutic oral sphere.
    Arrieta-Blanco JJ; Oñate-Sánchez R; Martínez-López F; Oñate-Cabrerizo D; Cabrerizo-Merino MD
    Med Oral Patol Oral Cir Bucal; 2014 May; 19(3):e280-8. PubMed ID: 24121923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of autologous platelet-rich clots for the prevention of local injury bleeding in patients with severe inherited mucocutaneous bleeding disorders.
    Nurden P; Youlouz-Marfak I; Siberchicot F; Kostrzewa E; Andia I; Anitua E; Nurden AT
    Haemophilia; 2011 Jul; 17(4):620-4. PubMed ID: 21323803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
    Kurth AA; Ludwig G; Scharrer I
    Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G; Federici AB; Rodeghiero F; Mannucci PM
    Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.